Back to search

Article

SARS Vaccine Development

2005-07-01

Abstract excerpt

Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)–associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it is easy to generate; however, safety is the main concern. The spike (S) protein of SARS-CoV is the major inducer of neutralizing antibodies, and the receptor-binding d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a9cf17c-3843-5eab-a867-55dfe1dc1b1f
DOI
10.3201/eid1107.050219
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS Vaccine DevelopmentDOI 10.3201/eid1107.050219
Select a neighboring publication to make it the new centre.